Smith Thornton Advisors LLC Johnson & Johnson Transaction History
Smith Thornton Advisors LLC
- $191 Billion
- Q3 2025
A detailed history of Smith Thornton Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Smith Thornton Advisors LLC holds 4,166 shares of JNJ stock, worth $831,450. This represents 0.41% of its overall portfolio holdings.
Number of Shares
4,166
Previous 4,048
2.92%
Holding current value
$831,450
Previous $618 Million
24.94%
% of portfolio
0.41%
Previous 0.36%
Shares
6 transactions
Others Institutions Holding JNJ
# of Institutions
4,831Shares Held
1.74BCall Options Held
19.8MPut Options Held
16.8M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...